Thalassemia News and Research

Latest Thalassemia News and Research

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Metallic copper surfaces kill bacteria on contact

Metallic copper surfaces kill bacteria on contact

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Medication and blood transfusion reduce risk of recurrent strokes in young patients with sickle cell anemia

Medication and blood transfusion reduce risk of recurrent strokes in young patients with sickle cell anemia

Research highlighting treatment for pediatric SCD, malaria presented at ASH 2010

Research highlighting treatment for pediatric SCD, malaria presented at ASH 2010

Study compares efficacy of two treatments for iron overload caused by chronic transfusion therapy

Study compares efficacy of two treatments for iron overload caused by chronic transfusion therapy

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

ENERCA network organizes European Symposium on rare anemias

ENERCA network organizes European Symposium on rare anemias

CINJ experts to comment on importance of blood donation

CINJ experts to comment on importance of blood donation

New mathematical model may help predict anemia risk

New mathematical model may help predict anemia risk

StemCyte receives two cash grants under QTDP program for biomedical research

StemCyte receives two cash grants under QTDP program for biomedical research

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

FerroKin BioSciences initiates international Phase 2 study of FBS0701

FerroKin BioSciences initiates international Phase 2 study of FBS0701

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

HemaQuest closes additional $4M to Series B financing

HemaQuest closes additional $4M to Series B financing

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans